Australia's Microba Life Sciences jumps on distribution deal with Sonic Healthcare
** Shares of Microba Life Sciences MAP.AX jump as much as
5% to A$0.315
** Co and Sonic Healthcare SHL.AX sign commercial
agreement for distribution of MAP's infectious disease test
MetaPanel
** Metapanel can identify multiple pathogens simultaneously
from a single sample and was developed in partnership with
Australian hospitals
** SHL owns 23.16% stake in MAP
** Stock down ~9.8%% since ASX debut earlier this year as of
last close
(Reporting by Harish Sridharan in Bengaluru)
((harish.sridharan@thomsonreuters.com))
Recent news on Sonic Healthcare
See all newsAustralia's INOVIQ rises on Sonic Healthcare pact for ovarian cancer test
Cochlear, Sonic Healthcare fall on MSCI Australia Index exit
Australia's Sonic Healthcare slips to near 2-month low as Citi downgrades FY27 estimates
Australia's Sonic Healthcare falls after company flags impact to fiscal 2027 profit
Brief: MSCI Says There Will Be 184 Additions To The MSCI ACWI IMI Index